News & Blog

Author Archives: Tom Halkin

Creating Meaningful Change, With a Little Help From our Friends

There are only four FDA-approved therapies to treat brain tumors. And in the last 17 years there have been approximately 75 potential new drugs that have failed during the clinical trial process to prove they are safe and effective for patients, while only three that have won FDA approval[1]. That is a 25:1 failure ratio. […]

A New “America’s Neuro-Oncologist” at the National Cancer Institute

Yesterday, it was announced that Dr. Mark R. Gilbert, MD, has been named Chief of the Neuro-Oncology Branch (NOB) at the National Institutes of Health (NIH), within the Center for Cancer Research of the National Cancer Institute (NCI). In this position, Dr. Gilbert – previously Deputy Chairman of the Department of Neuro-Oncology at MD Anderson […]

Hope for GBM Patients

Recent news and conversations across social media has churned up a lot of concern and fear over glioblastoma multiforme (GBM) tumors. And while we know all too well it’s the deadliest form of brain cancer with dismal survival rates, we also want the public to know how the National Brain Tumor Society is working to […]

Share